Vision Lifesciences

Catalyzing Life-Changing Collaborations

Your partner in cross-border licensing, partnerships, and deal-making for global pharma and life sciences.

In-Licensing

Acquire rights to innovative therapeutics and technologies.

Out-Licensing

Monetize your IP and product portfolios globally.

Strategic Partnerships

Build cross-border alliances in pharma and biotech.

Global Network

Deep connections across Asia, Europe, and USA.

Vision Lifesciences

Your Partner in Cross-Border Life Sciences Deals

We facilitate global partnerships and financing in life sciences, connecting Asia, Europe, and USA to accelerate innovation to market.

3
Continents
100+
Deals Facilitated
$2B+
Transaction Value

Solutions for Life Sciences Cross-Border Collaborations

In-Licensing. Acquire rights to innovative therapeutics and technologies from global partners.

In-licensing deals and partnerships

Out-Licensing. Monetize your IP and product portfolios through strategic licensing agreements.

Out-licensing opportunities

Strategic Partnerships. Build cross-border alliances for drug development, manufacturing, and commercialization.

50+
Partners

NewCo Formation. Spin off assets into new independent entities to access global capital and expertise.

15+
NewCos Formed

Capital Access. Connect clients with investors and structure financial deals from seed to late-stage.

$500M+
Raised

Core Capabilities for Pharmaceutical and Biotech Success

Our specialized knowledge and vast connections make us the ideal catalyst for cross-border collaborations in the life sciences industry.

Maximize value in licensing transactions.

We facilitate in-licensing agreements, balancing upfront payments, milestones, and royalties for optimal outcomes. Our expertise ensures you secure the right assets at the right terms.
In-Licensing

Latest Insights

Looking for hidden opportunities in global pharma? Our insights reveal them.

The Rise of Biopharma in China: Trends and Future Outlook

The Rise of Biopharma in China: Trends and Future Outlook

Exploring the rapid growth of China's biopharmaceutical sector.

M&A Activity in 2024: Biopharma's Year of Strategic Consolidation

M&A Activity in 2024: Biopharma's Year of Strategic Consolidation

A comprehensive analysis of merger and acquisition trends.

Global Pharma in 2024: The Surge of East-West Collaboration

Global Pharma in 2024: The Surge of East-West Collaboration

How cross-border partnerships are driving innovation.

Frequently Asked Questions

Looking for a Collaboration?

Let's discuss how we can help you accelerate your cross-border deals in pharma and life sciences.